CLINICAL ANALYTICS FOR POPULATION HEALTH MANAGEMENT MARKET TRENDS REPORT SPECIAL EXCERPT PREPARED FOR GENEIA LLC

Transcription

1 2016 CLINICAL ANALYTICS FOR POPULATION HEALTH MANAGEMENT MARKET TRENDS REPORT SPECIAL EXCERPT PREPARED FOR GENEIA LLC

2 ABOUT CHILMARK RESEARCH ABOUT CHILMARK RESEARCH ABOUT CHILMARK RESEARCH ABOUT CHILMARK RESEARCH Chilmark Research is a global advisory firm whose sole focus is market for healthcare IT solutions. Chilmark This focus Research allows us is to a global provide our clients with advisory most firm whose in-depth sole focus accurate is market for on healthcare critical IT technology solutions. Chilmark This adoption focus Research allows trends us is to a occurring global provide our throughout clients with advisory healthcare most firm whose in-depth sector. sole Areas focus accurate of is current market for on healthcare focus critical include IT technology solutions. among Chilmark This Research is a global advisory firm whose sole focus is market for healthcare IT solutions. ors: adoption focus Clinician allows trends Network us to occurring provide Management, our throughout clients Cloud-computing with healthcare most in-depth sector. Models Areas for accurate Healthcare, of current IT-enabled on focus critical Accountable include technology among Care This focus allows us to provide our clients with most in-depth accurate on critical technology ors: Organizations, adoption Clinician trends Care Network Coordination, occurring Management, throughout Adoption Cloud-computing of Mobile healthcare Technology sector. Models Areas for Consumer-facing Healthcare, of current IT-enabled Health focus Accountable include Wellness among Care Applications ors: adoption trends occurring throughout healthcare sector. Areas of current focus include among Organizations, Clinician Services. Care Network Coordination, Management, Adoption Cloud-computing of Mobile Technology Models for Consumer-facing Healthcare, IT-enabled Health Accountable Wellness Care Applications ors: Clinician Network Management, Cloud-computing Models for Healthcare, IT-enabled Accountable Care Organizations, Services. Care Coordination, Adoption of Mobile Technology Consumer-facing Health Wellness Applications Using a pragmatic, Services. Care Organizations, evidence-based Coordination, Adoption of methodology Mobile Technology with a strong Consumer-facing emphasis on primary Health, Wellness Chilmark Applications Services. Using Research a pragmatic, structures evidence-based its reports to serve methodology needs with of a technology strong emphasis adopters, on primary consultants,, investors Chilmark Using Research technology a pragmatic, structures vendors. evidence-based In its addition to reports to for serve methodology general needs market, with of a technology Chilmark strong emphasis Research adopters, on performs primary consultants,, investors for Chilmark clients Using Research a pragmatic, structures evidence-based its reports to serve methodology needs with of a technology strong emphasis adopters, on primary consultants,, investors Chilmark technology based on ir vendors. specific In needs. addition Such to reports for has included general market, competitive Chilmark analyses, Research market performs opportunity assessments, for clients Research technology structures vendors. In its addition to reports to for serve general needs market, of technology Chilmark Research adopters, performs consultants, investors for clients based strategic on assessment ir specific of needs. market Such vendors for has partnership included competitive /or acquisition. analyses, market opportunity assessments, technology based on ir vendors. specific In needs. addition Such to reports for has included general market, competitive Chilmark analyses, Research market performs opportunity assessments, for clients strategic assessment of market vendors for partnership /or acquisition. based strategic In 2012, on Chilmark assessment ir specific Research of needs. market launched Such vendors its newest for has partnership included service, competitive /or Chilmark acquisition. analyses, Advisory market Service opportunity (CAS). The CAS assessments, was created 2012, in direct Chilmark response Research to clients launched request its newest for a continuous service, feed Chilmark of Advisory on Service most (CAS). pertinent The CAS trends was in cre- strategic assessment of market vendors for partnership /or acquisition. In In ated adoption 2012, in direct Chilmark use response of Research healthcare to clients launched IT. request This its is newest an for annual a continuous service, subscription feed Chilmark that of provides Advisory on not Service only most access (CAS). pertinent to The a number CAS trends was in of created 2012, in direct Chilmark response Research to clients launched request its newest for a continuous service, feed Chilmark of Advisory on Service most (CAS). pertinent The CAS trends was in cre- search reports use throughout of healthcare year, IT. This but is also an annual direct access subscription to Chilmark that provides Research not analysts only access to answer to a number specific of client In adoption needs. reports Please contact throughout us directly year, for but furr also information direct access about to Chilmark CAS. Research analysts to answer specific client ated adoption in direct use response of healthcare to clients IT. request This is an for annual a continuous subscription feed that of provides on not only most access pertinent to a number trends in of reports use throughout of healthcare year, IT. This but is also an annual direct access subscription to Chilmark that provides Research not analysts only access to answer to a number specific of client re- adoption needs. Please contact us directly for furr information about CAS. search needs. Chilmark reports Please Research contact throughout is proud us directly of year, for clients but furr also it has information direct had access pleasure about to Chilmark CAS. to serve Research including analysts Abbott to Labs, answer Bluetooth specific Special client needs. Please contact us directly for furr information about CAS. Chilmark Interest Group, Research Catholic is proud Healthcare of clients East, it Cerner, has had HCA, pleasure Highmark, to IBM, serve Kaiser-Permanente, including Abbott Labs, McKesson, Bluetooth McKinsey, Special Chilmark Interest Microsoft, Group, Research Thomson Catholic is proud Healthcare Reuters of to clients East, name it Cerner, a has few. had It HCA, is our pleasure Highmark, hope that to IBM, serve at some Kaiser-Permanente, including future Abbott date we Labs, will McKesson, have Bluetooth McKinsey, pleasure Special Chilmark Interest Group, Research Catholic is proud Healthcare of clients East, it Cerner, has had HCA, pleasure Highmark, to IBM, serve Kaiser-Permanente, including Abbott Labs, McKesson, Bluetooth McKinsey, Special Microsoft, to serve you as Thomson well. Reuters to name a few. It is our hope that at some future date we will have pleasure Interest Microsoft, Group, Thomson Catholic Healthcare Reuters to East, name Cerner, a few. It HCA, is our Highmark, hope that IBM, at some Kaiser-Permanente, future date we McKesson, will have McKinsey, to serve you as well. pleasure Microsoft, to serve you as Thomson well. Reuters to name a few. It is our hope that at some future date we will have pleasure to serve you as well. 745 Atlantic Ave., Suite Atlantic Ave., Suite Atlantic Ave., Suite 901 info@chilmark.com 745 Atlantic Ave., Suite 901 info@chilmark.com info@chilmark.com info@chilmark.com without prior permission of Chilmark Research. The information contained within report is not intended as a solicitation of an offer to buy without prior permission of Chilmark Research. The information contained within report is not intended as a solicitation of an offer to buy without prior permission of Chilmark Research. The information contained within report is not intended as a solicitation of an offer to buy without prior permission of Chilmark Research. The information contained within report is not intended as a solicitation of an offer to buy FEBRUARY 2016 CHILMARK RESEAR C H 2016 FEBRUARY 2016 CHILMARK RESEAR C H 2016 CHILMARK

3 SCOPE AND METHODOLOGY SCOPE AND METHODOLOGY FEBRUARY 2016 To compile this report, Chilmark Research combined extensive primary secondary techniques to create a composite profile for each vendor. Primary was divided into two distinct steps, beginning with soliciting targeted vendors for ir involvement in. Of vendors profiled in this report, only Optum Verisk declined to participate. Rar than omit se two important vendors, or perform only stard secondary, we were able to gar data on se companies through interviews with HCOs, competitors, To compile this report, Chilmark Research combined extensive primary secondary techniques to create a composite profile for each vendor. Primary was divided into two distinct steps, beginning with so- former employees. liciting targeted vendors for ir involvement in. Of vendors profiled in this report, only Optum We asked participating vendors to complete a detailed questionnaire whose purpose was to collect qualitative Verisk declined to participate. Rar than omit se two important vendors, or perform only stard quantitative information about company markets it serves. Questions included among ors: 2015 secondary, we were able to gar data on se companies through interviews with HCOs, competitors, revenue projected 2016 revenue, number of employees, primary market, number of healthcare entities currently using its solution, more in-depth questions regarding solution features functions. As this is still an former employees. immature market, many vendors were reluctant to share some metrics regarding ir business for competitive We asked participating vendors to complete a detailed questionnaire whose purpose was to collect qualitative reasons. In such situations, we provide estimates based on knowledge of market, common operational metrics, quantitative information about company markets it serves. Questions included among ors: 2015 a vendor s overall position in market. revenue projected 2016 revenue, number of employees, primary market, number of healthcare entities currently using its solution, more in-depth questions regarding solution features functions. As this is still an Upon receiving completed questionnaire, we conducted a follow-up interview with each vendor. These indepth telephone interviews typically lasted 60 minutes were used to clarify responses to questionnaire. immature market, many vendors were reluctant to share some metrics regarding ir business for competitive reasons. In such situations, we provide estimates based on knowledge of market, common operational metrics, This portion of effort also focused on topics that cannot easily be captured within context of a a vendor s overall position in market. written questionnaire including competitive positioning, product roadmap, partnership strategy, which solution features are most attractive to prospective customers. Upon receiving completed questionnaire, we conducted a follow-up interview with each vendor. These indepth telephone interviews typically lasted 60 minutes were used to clarify responses to questionnaire. Chilmark Research performed a final analysis of vendors via secondary telephone interviews with This portion of effort also focused on topics that cannot easily be captured within context of a end users consultants that have advised on, deployed, or used a vendor s system. This information was compiled to provide in-depth reviews ratings of profiled vendors. Prior to publication, all vendors were written questionnaire including competitive positioning, product roadmap, partnership strategy, which solution features are most attractive to prospective customers. given an opportunity to review ir profile narratives (not rankings) for fact checking. Their comments feedback were considered where relevant, incorporated into final profile narratives. Chilmark Research performed a final analysis of vendors via secondary telephone interviews with In compiling this extensive report, Chilmark Research maintained absolute objectivity throughout entire process (sometimes to a vendor s chagrin) it is our sincere hope that this report brings greater clarity to end users consultants that have advised on, deployed, or used a vendor s system. This information was compiled to provide in-depth reviews ratings of profiled vendors. Prior to publication, all vendors were this developing market. given an opportunity to review ir profile narratives (not rankings) for fact checking. Their comments feedback were considered where relevant, incorporated into final profile narratives. In compiling this extensive report, Chilmark Research maintained absolute objectivity throughout entire process (sometimes to a vendor s chagrin) it is our sincere hope that this report brings greater clarity to this developing market ANALYTICS FOR POPULATION HEALTH MANAGEMENT EXCERPT

4 FEBRUARY 2016 ANALYTICS VENDORS TECHNOLOGY FOR PHM INITIATIVES Without a robust sales, marketing, support strategy, a product rarely succeeds in market. Analytics solutions that enable population health management (PHM) are maturing but not all healthcare organizations (HCO) are well informed of options. Moreover, implementing an analytics solution requires skills expertise that many HCOs eir do not have or cannot allocate given competing priorities resource constraints. To set stage, Figure 1 depicts our high-level conclusions about product capabilities vision demonstrated by some of most prominent vendors in market. Health Catalyst Cerner Product Vision IBM Watson Health Truven HealthEC ABCO Conifer Wellcentive Optum Arcadia Geneia Caradigm CareEvolution Epic eclinicalworks Aetna AHM McKesson Aetna HDMS Premier, Inc. Verisk Health Product Capabilities Figure 1: Vendor Product Capabilities versus Product Vision As this figure suggests, vendor product capabilities remain immature. In aggregate, feature sets are not entirely equal to dems of an HCO market that is straddling FFS-VBR payment regimes nor are y well suited to constrained IT implementation capabilities of overwhelming majority of HCOs. However, most vendors underst challenges faced by ir HCO customers as shown in our estimation of vendor s Product Vision.

5 Geneia Profile Highlights: ANALYTICS VENDORS TECHNOLOGY FOR PHM INITIATIVES Top three differentiators: Or quotes: Geneia tackles data integration with gusto. Underlying this set of applications is a comprehensive consolidated patient record consisting of clinical, claims device data. Health Catalyst The company was founded to help bring risk utilization Cerner analytics rigor to risk-bearing HCOs. Wellcentive Caradigm All of se [technology] IBM Watson partnerships Health involve marquee CareEvolution names that use modern technology. Unusually for an HIT-focused vendor, Geneia Optum offers education training to anyone, not just users of its technology. Truven HealthEC Geneia has a strong appeal for payers Arcadia health plans. Epic ABCO Geneia Chilmark Research selected Geneia Conifer as one of 20 most eclinicalworks prominent analytics vendors in population health management. Product Vision To be selected, a vendor must have at least three customers live on ir solution $1 million in revenue from ir analytics suite. McKesson Premier, Inc. Aetna AHM A number of well-known companies were considered but not selected for inclusion in report: IBM Aetna HDMS Watson Health, Oracle Health, Orion Health, SAP AG, Tableau, Transcend Insights. Verisk Health Chilmark Research awarded Product Marketing grades to each vendor. The grades for Geneia: Product Capabilities B- Product Capabilities Product Vision B- Market Execution C+ Figure 1: Vendor Product Capabilities versus Product Vision Market Vision B+ FEBRUARY 2016 Without a robust sales, marketing, support strategy, a product rarely succeeds in market. Analytics solutions that enable population health management (PHM) are maturing but not all healthcare organizations (HCO) 2. Deep claims expertise 1. Strong, modern technology are well informed of options. Moreover, implementing an analytics solution requires skills expertise that 3. Good option for employer plans many HCOs eir do not have or cannot allocate given competing priorities resource constraints. To set stage, Figure 1 depicts our high-level conclusions about product capabilities vision demonstrated by some of most prominent vendors in market. Strengths: Population health vision based on organizational change As this figure suggests, vendor product capabilities remain immature. In aggregate, feature sets are not entirely equal to dems of an HCO market that is straddling FFS-VBR payment regimes nor are y well No A s were awarded to any of 20 vendors profiled. suited to constrained IT implementation capabilities of overwhelming majority of HCOs. However, In Product Capabilities category, Geneia s grade was a B-. The highest grade awarded was a B+. Five most vendors underst challenges faced by ir HCO customers as shown in our estimation of vendor s or also received a B-. Eight were below a B- six were above a B-. Product Vision. In Product Vision category, Geneia s grade was a B-. The highest grade awarded was an A-; only one vendor received that grade. Two or vendors received a B-. Seven vendors were below a B- 10 vendors were above a B-.

6 FEBRUARY 2016 ANALYTICS VENDORS TECHNOLOGY FOR PHM INITIATIVES Geneia highlights from Vendor Product Ratings: In Claims Data, Geneia received along with Aetna AHM, McKesson, Optum, Premier, Truven, Verisk, Wellcentive. No vendor scored higher. In Provider Benchmark, Geneia received along with Advisory Board, Aetna HDMS, Arcadia, Caradigm, CareEvolution, Cerner, Conifer, eclinicalworks, Epic, Health Catalyst, HealthEC, McKesson, Optum, Premier, Health Truven. Catalyst No vendor scored higher. Cerner In Care Gaps, Geneia received along with Advisory Board, Aetna AHM, Aetna HDMS, Caradigm, CareEvolution, Conifer, eclinicalworks, Wellcentive HealthEC, Caradigm IBM Watson, McKesson, Optum, Premier, Truven. IBM No Watson vendor Health scored higher. CareEvolution In Quality Reporting, Geneia received a Optum along with every or vendor except Aetna AHM which received a. No vendor Truvenscored higher. HealthEC Arcadia Epic Geneia highlights from Vendor Market ABCO Ratings: Geneia In Solution Scope, Geneia received Conifer because eclinicalworks company can provide clinical services. Aetna AHM, Aetna HDMS, Conifer, Optum also received. No vendor scored higher. Product Vision Aetna AHM McKesson Aetna HDMS Premier, Inc. Verisk Health Product Capabilities Figure 1: Vendor Product Capabilities versus Product Vision In Market Execution category, Geneia s grade was a C+. The highest grade awarded was an A-; only one vendor received that grade. Four or vendors received a C+. Four vendors were below a C+ Without a robust sales, marketing, support strategy, a product rarely succeeds in market. Analytics solutions that enable population health management (PHM) are maturing but not all healthcare organizations (HCO) 11 vendors were above a C+. are well informed of options. Moreover, implementing an analytics solution requires skills expertise that In Market Vision category, Geneia s grade was a B+. The highest grade awarded was an A-; only one many HCOs eir do not have or cannot allocate given competing priorities resource constraints. To set vendor received that grade. Three or vendors received a B+. Fifteen vendors were below a B+ stage, Figure 1 depicts our high-level conclusions about product capabilities vision demonstrated by one vendor one that received A- - was above a B+. some of most prominent vendors in market. As this figure suggests, vendor product capabilities remain immature. In aggregate, feature sets are not entirely equal to dems of an HCO market that is straddling FFS-VBR payment regimes nor are y well suited to constrained IT implementation capabilities of overwhelming majority of HCOs. However, most vendors underst challenges faced by ir HCO customers as shown in our estimation of vendor s Product Vision.